POLX.L Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 11:16):

Polarean Imaging plc operates as a medical drug-device combination company serving the medical imaging market in the United States, Canada, Germany, and the United Kingdom...

Stats
Today's Volume	288 618
Average Volume	850 364
Market Cap	8.43M
EPS	£0 ( 2023-09-14 )
Next earnings date	( £0 ) 2024-05-23
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	-0.780
ATR14	£0.0690 (1.76%)

Polarean Imaging PLC Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Polarean Imaging PLC Financials

Annual	2022
Revenue:	£1.03M
Gross Profit:	£348 276 (33.71 %)
EPS:	£-0.0667

Q2	2023
Revenue:	£71 192.00
Gross Profit:	£40 950.00 (57.52 %)
EPS:	£-0.0173

Q1	2023
Revenue:	£71 192.00
Gross Profit:	£40 950.00 (57.52 %)
EPS:	£-0.0173

Q4	2022
Revenue:	£99 460.00
Gross Profit:	£26 718.00 (26.86 %)
EPS:	£-0.0164

Financial Reports:

No articles found.

Polarean Imaging PLC

Polarean Imaging plc operates as a medical drug-device combination company serving the medical imaging market in the United States, Canada, Germany, and the United Kingdom. The company engages in the development and commercialization of gas polarizer devices and ancillary instruments. It develops equipment that enables existing magnetic resonance imaging (MRI) systems to achieve a level of pulmonary functional imaging and specializes in the use of hyperpolarized xenon gas (129Xe) as an imaging agent to visualize ventilation and gas exchange regionally in the smallest airways of the lungs, the tissue barrier between the lung and the bloodstream, and in the pulmonary vasculature; and a novel diagnostic approach. The company is also involved in the development and manufacture of MRI radiofrequency coils, which are required components for imaging 129Xe in the MRI system. Polarean Imaging plc was incorporated in 2016 and is based in Durham, North Carolina.